Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)

The detection of acquired copy-number abnormalities (CNAs) and copy-neutral loss of heterozygosity (CN-LOH) in neoplastic disorders by chromosomal microarray analysis (CMA) has significantly increased over the past few years with respect to both the number of laboratories utilizing this technology a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Fady M. Mikhail, Jaclyn A. Biegel, Linda D. Cooley, Adrian M. Dubuc, Betsy Hirsch, Vanessa L. Horner, Scott Newman, Lina Shao, Daynna J. Wolff, Gordana Raca
Materyal Türü: Artigo
Dil:İngilizce
Baskı/Yayın Bilgisi: 2019
Online Erişim:https://doi.org/10.1038/s41436-019-0545-7
https://www.nature.com/articles/s41436-019-0545-7.pdf
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!